Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-15 Primiano Christopher Brett EVP, CBO, GC & Secretary Exercise or conversion +9,675 13,328
2020-02-15 Primiano Christopher Brett EVP, CBO, GC & Secretary Exercise or conversion · Restricted Stock Units −9,675 29,025
2020-02-15 Shacham Sharon President & CSO Exercise or conversion +21,800 765,306
2020-02-15 Shacham Sharon President & CSO Exercise or conversion +21,800 563,939
2020-02-15 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −21,800 65,400
2020-02-15 Shacham Sharon President & CSO Exercise or conversion · Restricted Stock Units −21,800 65,400
2020-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion +21,800 563,939
2020-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion +21,800 765,306
2020-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −21,800 65,400
2020-02-15 Kauffman Michael Chief Executive Officer Exercise or conversion · Restricted Stock Units −21,800 65,400

Page 29 of 29 · 570 trades